Emiel A De Jaeghere
Overview
Explore the profile of Emiel A De Jaeghere including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
150
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Jaeghere E, Tuyaerts S, Van Nufel A, Belmans A, Bogaerts K, Baiden-Amissah R, et al.
Cancer Immunol Immunother
. 2024 Dec;
74(1):32.
PMID: 39738642
No abstract available.
2.
De Jaeghere E, Hamerlinck H, Tuyaerts S, Lippens L, Van Nuffel A, Baiden-Amissah R, et al.
Gynecol Oncol
. 2024 Nov;
191():275-286.
PMID: 39515198
Background: The phase II PRIMMO trial investigated a pembrolizumab-based regimen in patients with recurrent and/or metastatic cervical (CC) or endometrial (EC) carcinoma who had at least one prior line of...
3.
Fieuws C, Van der Meulen J, Proesmans K, De Jaeghere E, Loontiens S, Van Dorpe J, et al.
NPJ Precis Oncol
. 2024 Mar;
8(1):71.
PMID: 38519644
Ovarian cancer is the most lethal gynecologic malignancy, mainly due to late-stage diagnosis, frequent recurrences, and eventually therapy resistance. To identify potentially actionable genetic variants, sequencing data of 351 Belgian...
4.
Naert E, Van Hulle H, De Jaeghere E, Orije M, Roels S, Salihi R, et al.
Qual Life Res
. 2024 Feb;
33(5):1401-1414.
PMID: 38396183
Purpose: To assess experiences of sexuality and of receiving sexual healthcare in cervical cancer (CC) survivors. Methods: A qualitative phenomenological study using semistructured one-on-one interviews was conducted with 15 Belgian...
5.
Naert E, Decruyenaere A, Bultijnck R, De Jaeghere E, Orije M, Salihi R, et al.
Support Care Cancer
. 2023 Nov;
31(12):703.
PMID: 37975947
Purpose: To compare sexual/vaginal functioning between early cervical cancer (ECC) and locally advanced cervical cancer (LACC) survivors. Methods: VAMOS was a multicenter, cross-sectional, questionnaire, noninferiority study including ECC patients treated...
6.
De Jaeghere E, Tuyaerts S, Van Nuffel A, Belmans A, Bogaerts K, Baiden-Amissah R, et al.
Cancer Immunol Immunother
. 2022 Aug;
72(2):475-491.
PMID: 35960332
A phase II study (PRIMMO) of patients with pretreated persistent/recurrent/metastatic cervical or endometrial cancer is presented. Patients received an immunomodulatory five-drug cocktail (IDC) consisting of low-dose cyclophosphamide, aspirin, lansoprazole, vitamin...
7.
De Jaeghere E, Kanervo H, Colman R, Schrauwen W, West P, Vandemaele N, et al.
Cancers (Basel)
. 2022 Feb;
14(4).
PMID: 35205838
Purpose: This longitudinal survey study aimed to investigate the self-reported outcome measures of COVID-19 peritraumatic distress, depression, anxiety, stress, quality of life (QOL), and their associated factors in a cohort...
8.
Saerens M, De Jaeghere E, Kanervo H, Vandemaele N, Denys H, Naert E
Cancers (Basel)
. 2021 Sep;
13(18).
PMID: 34572830
Thromboembolic events are the second cause of death in cancer patients. In ovarian cancer, 3-10% of patients present with venous thromboembolism (VTE), but the incidence may rise to 36% along...
9.
Tandt H, Debruyckere I, Leyman L, Colman R, De Jaeghere E, Van Parys H, et al.
Psychiatr Q
. 2021 Jun;
92(4):1549-1563.
PMID: 34097247
The current study aimed to investigate the impact of the COVID-19 pandemic on the mental health of people with OCD and the degree of family accommodation (FA) by live-in family...
10.
Steenbrugge J, De Jaeghere E, Meyer E, Denys H, de Wever O
Cancer Res
. 2020 Oct;
81(1):27-34.
PMID: 32998999
Tumor-derived secretory factors orchestrate splenic hematopoietic and stromal cells to fuel metastasis. The spleen acts as a reservoir site for hematopoietic stem and progenitor cells, which are rapidly exploited as...